CDR2 Antikörper
-
- Target Alle CDR2 Antikörper anzeigen
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CDR2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human CDR2
- Isotyp
- IgG
- Top Product
- Discover our top product CDR2 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
- Andere Bezeichnung
- CDR2 (CDR2 Produkte)
- Synonyme
- CDR62 antikoerper, Yo antikoerper, cdr2 antikoerper, MGC69206 antikoerper, CDR2 antikoerper, AA617262 antikoerper, RGD1310578 antikoerper, cerebellar degeneration related protein 2 antikoerper, cerebellar degeneration related protein 2 L homeolog antikoerper, cerebellar degeneration-related 2 antikoerper, cerebellar degeneration-related protein 2 antikoerper, cerebellar degeneration related protein 2 like antikoerper, CDR2 antikoerper, cdr2 antikoerper, cdr2.L antikoerper, Cdr2 antikoerper, CDR2L antikoerper, LOC101060399 antikoerper
- Hintergrund
- CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.
- UniProt
- Q01850
-